InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by de Garidel Marc, Chairman & CEO. Insider active across 1 company, notably CinCor Pharma, Inc.. In total, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €177k. History available since 11 January 2022. The latest transaction was disclosed on 11 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to de Garidel Marc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
12,500 sharesCommon StockSEC:0001209191-23-012890:0
200,000 sharesCommon StockSEC:0001209191-23-005596:0
12,500 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-22-003186:0
Canonical exit: 11 Apr 2022 (T+90)
3 of 3 declarations
About de Garidel Marc
Marc de Garidel is the Chief Executive Officer of CinCor Pharma, Inc. In this role, he leads the company's operations and oversees the overall strategy. His leadership is essential in guiding research and development initiatives aimed at delivering innovative solutions in the healthcare sector.
